ロード中...
Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
BACKGROUND: Oestradiol with or without an anti-androgen (cyproterone acetate or spironolactone) is commonly prescribed in transfeminine individuals who have not had orchidectomy; however, there is no evidence to guide optimal treatment choice. OBJECTIVE: We aimed to compare add-on cyproterone acetat...
保存先:
| 出版年: | Endocr Connect |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Bioscientifica Ltd
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6612061/ https://ncbi.nlm.nih.gov/pubmed/31234145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-19-0272 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|